Paritaprevir, Ombitasvir, Ritonavir

Viekirax 12,5 mg/ 75 mg/ 50 mg comprimidos recubiertos con pelicula

75,0 mg + 12,5 mg + 50 mg comprimido recubierto con películaSpainWithdrawnAuthorised 3 Feb 2015

This page is kept for reference and is not offered to search engines.

In other countries

The same active substances on other registers, the same brand first.

ViekiraxEuropean Union · AbbVie Deutschland GmbH & Co. KGSame brand
ViekiraxRomania · 12.5 mg+ 75 mg + 50 mg · compr. film. · Abbvie Deutschland GMBH & Co. UKSame brand
VIEKIRAX 12.5mg/75mg/50mgRomania · 12.5mg/75mg/50mg · compr. film. · Abbvie LTDSame brand
VIEKIRAX film-coated tabletSaudi Arabia · Fournier Laboratories Ireland LimitedSame brand
TechnivieCanada · 12.5 MG + 75 MG + 50 MG · Tablet · Abbvie CorporationSame form
TechnivieUnited States · 12.5MG; 75MG; 50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · tablet · Abbvie

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Paritaprevir, Ombitasvir, Ritonavir

Viekirax 12,5 mg/ 75 mg/ 50 mg comprimidos recubiertos con pelicula

75,0 mg + 12,5 mg + 50 mg comprimido recubierto con películaSpainWithdrawnAuthorised 3 Feb 2015

Product informationAsk Osler about it

This page is kept for reference and is not offered to search engines.

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Packs

Pack	Code	Status
Viekirax 12,5 mg/ 75 mg/ 50 mg comprimidos recubiertos con pelicula 56 comprimidos	705022

Documents

The official texts, at the regulator.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substances: Paritaprevir, Ombitasvir, Ritonavir
Strength: 75,0 mg + 12,5 mg + 50 mg
Dosage form: comprimido recubierto con película
Route: vía oral
Register: Spain (AEMPS)
Status: Withdrawn
Status in the register: Revocado
Authorised: 3 Feb 2015
Registration: 114982001
Marketing authorisation holder: Abbvie Deutschland Gmbh & Co. Kg
Procedure: EU centralised
Supply: Diagnóstico Hospitalario